LungLife AI Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 18

Employees

  • Latest Deal Type
  • PIPE

  • Latest Deal Amount
  • $2.3M

  • Investors
  • 1

LungLife AI General Information

Description

LungLife AI Inc is focused on a developing clinical diagnostic solutions for lung cancer. The Company generates revenue from People's Republic of China and also has its presence in the United States of America.

Contact Information

Formerly Known As
Cynvenio, Cynvenio Biosystems
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 850 New Burton Road
  • Suite 201
  • Dover, DE 19904
  • United States
+1 (805)
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • 850 New Burton Road
  • Suite 201
  • Dover, DE 19904
  • United States
+1 (805)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

LungLife AI Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. PIPE 21-Mar-2024 $2.3M Completed Generating Revenue
10. IPO 08-Jul-2021 Completed Generating Revenue
9. Later Stage VC 25-May-2021 Completed Generating Revenue
8. Later Stage VC 04-Dec-2020 Completed Generating Revenue
7. Later Stage VC (Series B) 04-Jun-2015 Completed Generating Revenue
6. Later Stage VC 02-Sep-2014 Completed Startup
5. Early Stage VC (Series B) 25-Nov-2013 Completed Startup
4. Early Stage VC (Series B) 26-Nov-2012 Completed Startup
3. Grant 31-Jul-2012 $1.4M $3.94M Completed Startup
2. Early Stage VC (Series B2) 29-Nov-2011 $1.97M $3.94M Completed Startup
To view LungLife AI’s complete valuation and funding history, request access »

LungLife AI Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view LungLife AI’s complete cap table history, request access »

LungLife AI Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
LungLife AI Inc is focused on a developing clinical diagnostic solutions for lung cancer. The Company generates revenue
Diagnostic Equipment
Dover, DE
18 As of 2025

New Haven, CT
 

Forchheim, Germany
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

LungLife AI Competitors (2)

One of LungLife AI’s 2 competitors is Precipio, a Formerly VC-backed company based in New Haven, CT.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Precipio Formerly VC-backed New Haven, CT
Siemens Healthineers Corporation Forchheim, Germany
You’re viewing 2 of 2 competitors. Get the full list »

LungLife AI Patents

LungLife AI Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4532772-A1 Methods for detecting circulating genetically abnormal cells Inactive 24-May-2022
US-20260152798-A1 Methods for detecting circulating genetically abnormal cells Pending 24-May-2022
WO-2023230531-A1 Methods for detecting circulating genetically abnormal cells Inactive 24-May-2022
EP-4172370-A1 Methods for detecting lung cancer Inactive 30-Jun-2020
US-20230266325-A1 Methods for detecting lung cancer Pending 30-Jun-2020 G01N33/5752
To view LungLife AI’s complete patent history, request access »

LungLife AI Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

LungLife AI Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Maven Capital Partners UK PE/Buyout Minority
To view LungLife AI’s complete investors history, request access »

LungLife AI Investments (1)

LungLife AI’s most recent deal was a Joint Venture with Sanmed Biotech. The deal was made on 14-Mar-2016.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Sanmed Biotech 14-Mar-2016 Joint Venture Diagnostic Equipment
To view LungLife AI’s complete investments history, request access »

LungLife AI ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Services

Subindustry

Rank

Percentile

To view LungLife AI’s complete esg history, request access »

LungLife AI FAQs

  • When was LungLife AI founded?

    LungLife AI was founded in 2009.

  • Where is LungLife AI headquartered?

    LungLife AI is headquartered in Dover, DE.

  • What is the size of LungLife AI?

    LungLife AI has 18 total employees.

  • What industry is LungLife AI in?

    LungLife AI’s primary industry is Diagnostic Equipment.

  • Is LungLife AI a private or public company?

    LungLife AI is a Private company.

  • What is LungLife AI’s current revenue?

    The current revenue for LungLife AI is .

  • How much funding has LungLife AI raised over time?

    LungLife AI has raised $71.7M.

  • Who are LungLife AI’s investors?

    Maven Capital Partners UK has invested in LungLife AI.

  • Who are LungLife AI’s competitors?

    Precipio and Siemens Healthineers are competitors of LungLife AI.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process